New study shows intermittent HT as effective as continuous HT
Options
vartabebo
Member Posts: 10
This report was apparently published today at the annual meeting of the American Society of Clinical Oncology...
http://www.medicalnewstoday.com/releases/227668.php
http://www.medicalnewstoday.com/releases/227668.php
0
Comments
-
NCCN may alter their guidelines
Arthur
Great news. These findings will influence the importance given to the newer drugs as well (such as Abiraterone acetate), which do not make part of the protocols of the patients/cases used in the trials but have proven effectiveness with lesser side effects.
I hope institutions like NCCN will alter their guidelines and introduce newer measures regarding HT, based on truthful results like these.
Here is the abstract of the trials;
http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=102&abstractID=77775
Thanks for posting the article.
VG0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 122.4K Cancer specific
- 2.8K Anal Cancer
- 453 Bladder Cancer
- 310 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 406 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 679 Leukemia
- 799 Liver Cancer
- 4.2K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 240 Multiple Myeloma
- 7.2K Ovarian Cancer
- 68 Pancreatic Cancer
- 493 Peritoneal Cancer
- 5.6K Prostate Cancer
- 1.2K Rare and Other Cancers
- 544 Sarcoma
- 742 Skin Cancer
- 659 Stomach Cancer
- 192 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.4K Lifestyle Discussion Boards